Tous Actualités
Suivre
Abonner LifeWatch AG

LifeWatch AG

EANS-Adhoc: LifeWatch AG: Kenneth Melani designated as new Chairman. Yacov Geva will continue to act as the Corporate CEO. (with document)

Un document

--------------------------------------------------------------------------------
  ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
  distribution. The issuer is solely responsible for the content of this
  announcement.
--------------------------------------------------------------------------------
Board of Directors (Appointments and Changes)/Company Information/LifeWatch AG
25.03.2013


Neuhausen am Rheinfall/Switzerland - LifeWatch AG (SIX Swiss Exchange: LIFE),
the leading provider of wireless telemedicine, today announces a change for the
Chair of its Board of Directors. Subject to his re-election at the upcoming
ordinary shareholder meeting on May 29, 2013, the current Board member Kenneth
Melani will then take the Chair of the Board of Directors. The present Chairman
and CEO Dr. Yacov Geva will continue to act as the Corporate CEO of LifeWatch
AG.

You will find a PDF-version of this press release at the end of this message.


LifeWatch AG announces today that its Board member Kenneth Melani will take the
Chair of the Board of Directors from Dr. Yacov Geva subject to his re-election
at the upcoming ordinary shareholder meeting on May 29, 2013. On the occasion of
the extraordinary shareholder meeting on January 23, 2013, Kenneth Melani was
elected a member of the Board based on his longstanding experience and intimate
knowledge of the U.S. healthcare system. Currently, the Company is creating
about 99% of its revenues in the United States.

The long-time Chairman and Chief Executive Officer of LifeWatch AG, Dr. Yacov
Geva, will continue to act as the Corporate CEO in order to grow the existing
and future business of the Company together with the new Chairman Kenneth
Melani.

Kenneth R. Melani (born 1954, citizen of the U.S.) is the former president and
chief executive officer of Highmark, a health insurance company based in
Pittsburgh and the largest health insurer in Pennsylvania. He graduated in 1975
with a chemistry degree and enrolled later in the Bowman Gray School of
Medicine in North Carolina before specializing in adult internal medicine. In
1982, he started his own practice in Pennsylvania. Later he began to take on
work for West Penn Cares, a company of West Penn-affiliated physicians,
developing business opportunities with a commercial blood laboratory and in-
home intravenous therapy devices. In 1989, he was appointed chief medical
officer for Blue Cross of Western Pennsylvania. During this time, Blue Cross of
Western Pennsylvania merged with Harrisburg's Pennsylvania Blue Shield and the
company was re-christened Highmark. Kenneth Melani was awarded W&J College's
"Entrepreneur of the Year Award" in 2009.


About LifeWatch AG:

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss
Exchange (LIFE), Switzerland, is the leading healthcare technology and solution
company, specializing in advanced telehealth systems and wireless remote patient
monitoring services. LifeWatch services cater to individuals, ranging from
high-risk and chronically ill patients, to consumers of health and wellness
products. LifeWatch AG has operative subsidiaries in the United States, in
Switzerland and in Israel and is the parent company of LifeWatch Services Inc.,
and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading US-based
provider of cardiac monitoring services and home sleep testing of Obstructive
Sleep Apnea (OSA). LifeWatch Technologies Ltd., based in Israel, is a leading
developer and manufacturer of telemedicine products. The Company is planning to
introduce the LifeWatch V, an Android-based smartphone with medical sensors and
apps that uses a cloud-based service platform. For additional information,
please visit www.lifewatch.com.

Sign-up for customized E-mail alerts and documentation requests is available at
http://production.investis.com/lifewatch/alert-service/

This press release includes forward-looking statements. All statements other
than statements of historical facts contained in this press release, including
statements regarding future results of operations and financial position,
business strategy and plans and objectives for future operations, are forward-
looking statements. The words "believe," "may," "will," "estimate," "continue,"
"anticipate," "intend,""expect" and similar expressions are intended to identify
forward-looking statements. LifeWatch AG has based these forward-looking
statements largely on current expectations and projections about future events
and financial trends that it believes may affect the financial condition,
results of operations, business strategy, short term and long term business
operations and objectives, and financial needs. These forward-looking statements
are subject to a number of risks, uncertainties and assumptions. In light of
these risks, uncertainties and assumptions, the forward-looking events
and circumstances described may not occur and actual results could differ
materially and adversely from those anticipated or implied in the forward-
looking statements. All forward-looking statements are based only on data
available to LifeWatch AG at the time of the issue of this press release.
LifeWatch AG does not undertake any obligation to update any forward-looking
statements contained in this press release as a result of new information,
future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND
SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A
GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT
CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES
FOR SALE IN THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY
SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN
ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD
OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT REGISTRATION
UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE
UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN
THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED
FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS
OF THE ISSUER.

Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/jG8iMykS

Further inquiry note:
Sensus Communication Consultants, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email  lifewatch@sensus.ch

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/jG8iMykS


issuer:      LifeWatch AG
             Rundbuckstrasse 6
             CH-8212 Neuhausen am Rheinfall
phone:       +41 52 632 00 50
FAX:         +41 52 632 00 51
mail:         users@lifewatch.com
WWW:      www.lifewatch.com
sector:      Healthcare Providers
ISIN:        CH0012815459
indexes:     SPI, SPIEX
stockmarkets: free trade: Berlin, Open Market / XETRA: Frankfurt, Main Standard:
             SIX Swiss Exchange 
language:   English

Plus de actualités: LifeWatch AG
Plus de actualités: LifeWatch AG